Most Read Articles
Yesterday
In patients with rheumatoid arthritis (RA) who are also positive for anticitrullinated protein antibodies (ACPA), tocilizumab (TCZ) treatment for 2 years increases femoral neck bone mineral density (BMD) and decreases concentrations of bone resorption markers, a recent study has found.
3 days ago
Long-term use of benzodiazepines is independently associated with lower diastolic and systolic blood pressure in ambulatory blood pressure monitoring (ABPM) among older but not younger patients, a study has found.
5 days ago
There appears to be a paradox in the context of smoking and the risk of psoriatic arthritis (PsA), such that current smoking increases the risk of developing PsA in the general population but protects against the same risk among patients with psoriasis, according to a study.
02 Nov 2017
In this issue of MIMS Anti-Infective Supplement, we bring you clinical updates related to combating infectious diseases, and also a symposium highlight in conjunction with the launch of ceftolozane/tazobactam (Zerbaxa; Merck Sharp & Dohme Sdn Bhd) in Malaysia. 

Psychodynamic therapy on par with CBT, pharmacotherapy in treating mental disorders

07 Oct 2017
Psychiatrists are health professionals who specialise in the field of mental health

Psychodynamic therapy is comparable with other established treatments, including pharmacotherapy and cognitive-behavioural therapy (CBT), in terms of efficacy, a recent study has shown.

Researchers formally tested the equivalence of psychodynamic therapy to treatments established in efficacy and controlled for researcher allegiance effects by including representatives of psychodynamic therapy and CBT, the main rival psychotherapeutic treatments (adversarial collaboration).

The formal criteria for testing equivalence was applied, implying a particularly strict test: a priori definition of a margin compatible with equivalence (g=0.25), using the two one-sided test procedure and ensuring the efficacy of the comparator. Independent raters evaluated effect sizes, study quality, as well as allegiance.

The following criteria were used in the systematic literature search: randomized controlled trial of manual-guided psychodynamic therapy in adults, testing psychodynamic therapy against a treatment with efficacy established for the disorder under study, and applying reliable and valid outcome measures. “Target symptoms” (eg, depressive symptoms in depressive disorder) was the main outcome.

A total of 23 randomized controlled trials with 2,751 patients met the inclusion criteria. Reliable rating methods showed that the mean quality of studies was good.

Based on statistical analyses, psychodynamic therapy was equivalent to comparison conditions for target symptoms at post-treatment (g=‒0.153; 90 percent equivalence CI, ‒0.227 to ‒0.079) and at follow-up (g=‒0.049; ‒0.137 to ‒0.038) since both CIs were included in the equivalence interval (‒0.25 to 0.25).

“Further research should examine who benefits most from which treatment,” according to researchers, adding that pharmacotherapy, CBT and psychodynamic therapy were the most frequently applied strategies for treatment of mental disorders.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
Yesterday
In patients with rheumatoid arthritis (RA) who are also positive for anticitrullinated protein antibodies (ACPA), tocilizumab (TCZ) treatment for 2 years increases femoral neck bone mineral density (BMD) and decreases concentrations of bone resorption markers, a recent study has found.
3 days ago
Long-term use of benzodiazepines is independently associated with lower diastolic and systolic blood pressure in ambulatory blood pressure monitoring (ABPM) among older but not younger patients, a study has found.
5 days ago
There appears to be a paradox in the context of smoking and the risk of psoriatic arthritis (PsA), such that current smoking increases the risk of developing PsA in the general population but protects against the same risk among patients with psoriasis, according to a study.
02 Nov 2017
In this issue of MIMS Anti-Infective Supplement, we bring you clinical updates related to combating infectious diseases, and also a symposium highlight in conjunction with the launch of ceftolozane/tazobactam (Zerbaxa; Merck Sharp & Dohme Sdn Bhd) in Malaysia.